We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Report on the service providing sterile, controlled environments for the preparation of injectable medicines into ready-to-administer formats for patients.
MHRA invites current and former suppliers to join Risk Ledger and complete a security profile to strengthen supply chain cyber security.
Provide innovators and developers of innovative products access to MHRA scientific expertise, regulatory guidance and an enhanced advice and signposting service.
How to comply with the regulations when using a medical device differently to the manufacturer's instructions.
The different types of tests and testing kits for COVID-19, and the specifications for manufacturers.
The Medicines and Healthcare Products Regulatory agency provides advice for producers of E-cigarette/vape products.
This guidance is designed to provide information on the implementation of changes to advertising and promotion of medicines authorised in the UK from 1 January 2025.
Device-specific guidance for manufacturers on reporting adverse incidents under the vigilance system.
Labelling requirements for e-liquids.
Guidance on labelling requirements pertinent to the type of medicinal product and its supply status, as defined in UK legislation.
Guidance for manufacturers of IVC filters. It outlines specific scenarios that should be considered when determining if an incident is reportable.
Find out about coronavirus (COVID-19) treatments available outside of hospital, including information on free prescriptions and lateral flow tests.
We use decades of experience in safe bioagent handling to support partners in research, development and testing of vaccines and therapeutics
Guidance for Marketing Authorisation (MA) applicants on providing consent to share operational information during the MA application process.
Guidance on registration of certain in vitro diagnostic devices reliant on expired or expiring CE certificates or declarations of conformity.
Directions setting out the integration of the Ministry of Defence (MoD) into the NHS Prescription Service.
For manufacturers reporting adverse incidents with intraocular lenses under the vigilance system.
The MHRA's initial plans on an Early Access service, which will be developed further throughout 2025.
Information for pharmaceutical wholesalers explaining the main changes the Windsor Framework introduces to the packaging for all medicines licensed in the UK, effective from 1 January 2025.
The call for applications for phase 2 of the AI Airlock is now closed.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).